Introduction
Hepatocellular carcinoma (HCC) is a leading liver-related cancer worldwide accounting for more than 600,000 cases every year; there is variation of the incidence of HCC with a higher incidence in Eastern Asia and sub-Saharan Africa. There are many known risk factors associated with the development of HCC, such as chronic hepatitis B and C infection, cirrhosis, nonalcoholic steatohepatitis and hereditary hemochromatosis [1] . The curative treatments for HCC are surgery such as hepatectomy or liver transplantation and local ablative treatments such as radiofrequency ablation or percutaneous ethanol injection. However, unfortunately only 20-30% of patients are suitable for this treatment. In case of unresectable HCC, the alternative treatments are transarterial chemoembolization (TACE) with or without systemic chemotherapy, whereas patients with terminal-stage disease receive only supportive treatment [2] . TACE is a standard treatment for patient with unresectable HCC without systemic metastases and has been reported to prolong survival and to control the symptoms of HCC. TACE is performed by injection of anti-cancer drugs such as doxorubicin, epirubicin, cisplatin or miriplatin and iodinized oil (Lipiodol Ultra-Fluide, Laboratoires Guerber, Aulnay-sous-Bois, France) into the hepatic artery followed by the administration of the embolic agents. The most common adverse events after TACE are nausea and vomiting, post-embolization syndrome, bleeding or transient hepatic impairment [3, 4] . The rare complications reported are duodenal perforation or hepatic abscess [5] , post-embolization hepatic rupture [6] , necrotizing pancreatitis [7] , spinal cord injury [8] , cerebral embolism [9, 10] , tumor lysis syndrome [11] or spontaneous bilo-enteric fistula [12, 13] .
Here, we reported a rare case of spontaneous hepaticoduodenal and choledochoduodenal fistula following TACE. Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent form is available for review from the editor of this journal.
Case Presentation
The patient was a 34-year-old gentleman, a known case of chronic hepatitis B with multifocal HCC who underwent right lobe hepatectomy with cholecystectomy 4 years ago. He had recurrent HCC at segment III and caudate lobe, thus he underwent three TACE procedures followed by wide caudate lobe resection couple years before. In this episode he presented with jaundice, high-grade fever and severe abdominal pain for 3 days. His blood works showed leukocytosis with neutrophilia. Liver chemistry showed hyperbilirubinemia which total/direct bilirubin 12.9/11.2 mg/dl (reference 0.2-1.0 mg/dl), aspartate transaminase and alanine transaminase were 75 and 53 U/l (reference 0-38 U/l), and alkaline phosphatase was 209 U/l (reference 39-117 U/l). Computed tomography showed a 6-mm common bile duct with mild left intrahepatic duct dilatation. Proximal left intrahepatic duct stricture was suspected; therefore, he was scheduled for endoscopic retrograde cholangiopancreatography and biliary drainage.
The patient was positioned in the left lateral decubitus position and sedated using intravenous propofol under full anesthetic monitoring. After duodenal intubation with a duodenoscope, a large duodenal ulcer was seen in the duodenal bulb, so the scope was changed to be standard gastroscope. The endoscopic view showed a 1.5-2.0-cm duodenal ulcer covered by yellowish debris tissue. After carefully checking the ulcer, two openings were seen at the ulcer base ( fig. 1 ) with whitish epithelial lining of the larger one, therefore a 0.035-inch guidewire was passed through these two nonsurgical openings ( fig. 2) followed by contrast injection. The authors found that one of the openings was a choledochoduodenal fistula and the other one a hepaticoduodenal fistula ( fig. 3 ). After revision of his surgical procedures, no surgical bypass was performed at all in this particular patient. The authors hypothesized that these fistulas were spontaneously created and might be the consequence of TACE pro-cedures which had caused ischemia and necrosis of the liver. The obstructive jaundice was due to the obstruction of the openings by food particles and a strictured bile duct at segments II and III, so two plastic stents (10 Fr, 7 cm) were inserted with good bile flow (fig. 4 ). The patient was followed up a month later. He was doing well and his liver chemistries were normal.
Discussion
Spontaneous bilo-enteric fistula is a very rare complications following some treatment interventions, the most common cause being surgery. There are only few case reports regarding this condition as an adverse events from severe inflammatory process such as acute pancreatitis or TACE [12] [13] [14] [15] . The principle of TACE is tumor ischemia that occurs from blocking of the arterial blood supply of the liver tumor combined with chemotherapy administered directly into the tumor. However, the normal liver tissue and adjacent organs can be affected by unintentional proximal artery embolization that leads to uncommon complications such as duodenal perforation or acute pancreatitis. In the present case, the fistulas might not only have been caused by repetitive TACE procedures, but also by altered anatomy from repetitive liver resections. In general, the definitive treatment of fistulas is surgical correction, but in this particular case, this might not have been possible because of inflammation and fibrosis of the surrounding tissue.
Leaving the fistula tracts opened might be an appropriate treatment strategy. Nevertheless, this patient still developed acute cholangitis that was complicated by obstruction of the fistula openings by food particles and proximal segmental bile duct stricture. Therefore, the authors planned for long-term biliary stenting in this patient. Finally, highly selective TACE is essential to prevent ischemia-related complications.
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